Laurie Keating Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity

ALNY Quotes by TradingView

Laurie Keating is EVP, Chief Legal Officer of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 5,132 shares of ALNY, which is worth approximately $1.38 Million. The most recent transaction as insider was on Aug 05, 2021, when has been sold 10,000 shares (Common Stock) at a price of $188.95 per share, resulting in proceeds of $1,889,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.13K
0% 3M change
0% 12M change
Total Value Held $1.38 Million

LAURIE KEATING Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 05 2021
SELL
Open market or private sale
$1,889,500 $188.95 p/Share
10,000 Reduced 66.09%
5,132 Common Stock
Aug 05 2021
BUY
Exercise of conversion of derivative security
$889,500 $88.95 p/Share
10,000 Added 39.79%
15,132 Common Stock
Jul 12 2021
SELL
Open market or private sale
$1,219,144 $178.97 p/Share
6,812 Reduced 57.03%
5,132 Common Stock
Jul 12 2021
BUY
Exercise of conversion of derivative security
$592,440 $86.97 p/Share
6,812 Added 36.32%
11,944 Common Stock
Jun 09 2021
SELL
Open market or private sale
$267,036 $154.0 p/Share
1,734 Reduced 25.25%
5,132 Common Stock
Apr 20 2021
SELL
Payment of exercise price or tax liability
$278,004 $133.08 p/Share
2,089 Reduced 23.33%
6,866 Common Stock
Apr 19 2021
BUY
Grant, award, or other acquisition
-
4,518 Added 33.53%
8,955 Common Stock
Feb 12 2021
SELL
Payment of exercise price or tax liability
$303,814 $154.77 p/Share
1,963 Reduced 30.67%
4,437 Common Stock
Feb 11 2021
BUY
Grant, award, or other acquisition
-
4,166 Added 39.43%
6,400 Common Stock
Jan 13 2021
SELL
Open market or private sale
$1,543,617 $171.0 p/Share
9,027 Reduced 80.16%
2,234 Common Stock
Jan 13 2021
BUY
Exercise of conversion of derivative security
$732,992 $81.2 p/Share
9,027 Added 44.49%
11,261 Common Stock
Jan 12 2021
SELL
Open market or private sale
$2,420,442 $162.0 p/Share
14,941 Reduced 86.99%
2,234 Common Stock
Jan 12 2021
BUY
Exercise of conversion of derivative security
$893,621 $59.81 p/Share
14,941 Added 46.52%
17,175 Common Stock
Jan 11 2021
SELL
Open market or private sale
$116,732 $154.0 p/Share
758 Reduced 25.33%
2,234 Common Stock

Also insider at

IMGO
Imago BioSciences, Inc. Healthcare
Director
IMRX
Immuneering Corp Healthcare
Director
PEPG
PepGen Inc. Healthcare
Director
LK

Laurie Keating

EVP, Chief Legal Officer
Cambridge, MA

Track Institutional and Insider Activities on ALNY

Follow ALNYLAM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNY shares.

Notify only if

Insider Trading

Get notified when an Alnylam Pharmaceuticals, Inc. insider buys or sells ALNY shares.

Notify only if

News

Receive news related to ALNYLAM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALNY